title: Aripiprazole induced Impulse Control Disorders: Where do we stand?
authors.affiliation: Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
authors.forename: Ananya
authors.initials: A
authors.lastname: Mahapatra
authors.affiliation: Arogin Health Care and Research Centre, Kathmandu, Nepal. Electronic address: Pawan60@gmail.com.
authors.forename: Pawan
authors.initials: P
authors.lastname: Sharma
authors.affiliation: Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Sagar
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068180:Aripiprazole / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D000068180:Aripiprazole